(Q53086538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

enzyme replacement therapy

7 February 2020

main subject

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Filippo Cademartiri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Marco Salvatore

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Giancarlo Messalli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Antonio Pisani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

G Avitabile

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

R Russo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

D Iodice

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

L Spinelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

S Dellegrottaglie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

9 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

Radiologia medica, rivista mensile

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

19-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21744250%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11547-011-0710-9

7 February 2020

exact match

0 references

cites work

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Onset and progression of the Anderson-Fabry disease related cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Fabry disease in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Neurological manifestations in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

The heart in Anderson-Fabry disease and other lysosomal storage disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11547-011-0710-9

Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment

21 January 2018

1 reference

12 December 2020

Natural history and treatment of renal involvement in Fabry disease.

1 reference

12 December 2020

MRI characterization of myocardial tissue in patients with Fabry's disease

1 reference

12 December 2020

Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of Anderson-Fabry disease

1 reference

12 December 2020

Clinical benefit of enzyme replacement therapy in Fabry disease

1 reference

12 December 2020

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease

1 reference

12 December 2020

1 reference

12 December 2020

Cardiac involvement in Fabry disease

1 reference

12 December 2020

Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy

1 reference

12 December 2020

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease

1 reference

12 December 2020